Forbes

PCOS has been renamed PMOS. Here's what the change means for the millions of women living with this misunderstood, often misdiagnosed condition

AI in healthcare is booming but the digital health divide is widening. How underserved communities are being tech-ignored.

A 3-hour WHO Hantavirus emergency Zoom call was held this morning, providing outbreak analysis. It seemed that for every question asked many more questions were raised.

High level resignations in protest against the push to allow sales of fruit-flavored vapes suggest a break in policy between the first and second Trump administrations.

Despite decades of digitization, healthcare still relies on fax machines, CDs and manual coordination to move patient information.

Why rare diseases like hantavirus generate fear while heart disease, loneliness, obesity, and poor sleep quietly cause far greater harm.

A bankruptcy court has approved the sale of CVS Health’s underperforming Omnicare long-term care pharmacy network to GenieRx in a deal valued at $250 million.

During a tumultuous 13-month tenure at the FDA, Makary pursued a wide range of ambitious initiatives. Going forward, their status under the next commissioner is unclear.

Most Americans support banning food dyes—but what drives diet quality is behavior, marketing and access. Removing dyes won’t fix what’s wrong with how we eat.

Isomorphic, which formed as an Alphabet company in 2021, has a massive cash horde, but it’s tight-lipped on what drugs it might bring to the clinic.

Editing a small number of blood-forming stem cells to encode powerful antibodies turns the immune system into a living drug factory.

In this week’s edition of InnovationRx, we look at the latest on the hantavirus outbreak, using quantum physics for metabolic MRIs, how AI can help fill prescriptions and more.

A public health expert explains why the United States is repeating the same mistake with the Hantavirus response as with COVID-19, particularly with communication and testing.